Benzinga's Top Downgrades

Analysts at Raymond James downgraded

from Outperform to Market Perform. Intuit shares closed at $105.44 on Friday. Oppenheimer downgraded

from Outperform to Perform. Marathon Oil shares closed at $18.40 on Friday. Analysts at JP Morgan downgraded

from Overweight to Neutral. The target price for Lexicon Pharmaceuticals has been raised from $9 to $14. Lexicon Pharmaceuticals shares closed at $11.38 on Friday. SunTrust Robinson Humphrey downgraded

from Buy to Neutral. Goldman Sachs BDC shares closed at $24.22 on Friday. Analysts at RBC Capital downgraded

from Outperform to Sector Perform. Viavi Solutions shares closed at $6.19 yesterday. Barclays downgraded

from Equal-weight to Underweight. The target price for Stonegate Mortgage has been lowered from $10 to $7. Stonegate Mortgage shares closed at $7.73 on Friday. Analysts Roth Capital downgraded

from Buy to Neutral. The target price for Keryx Biopharmaceuticals has been lowered from $11 to $6. Keryx Biopharmaceuticals shares closed at $6.26 on Friday. Goldman Sachs downgraded Westlake Chemical Corporation

from Neutral to Sell. The target price for Westlake Chemical has been lowered from $66 to $60. Westlake Chemical shares closed at $63.00 on Friday. Canaccord Genuity downgraded

from Buy to Hold. TELUS shares closed at $33.94 on Friday. Analysts at Stifel Nicolaus downgraded

from Buy to Hold. Southcross Energy shares closed at $8.78 on Friday.